Authors: DEMETER LM MEEHAN PM MORSE G FISCHL MA PARA M POWDERLY W LEEDOM J HOLDENWILTSE J GREISBERGER C WOOD K TIMPONE J WATHEN LK NEVIN T RESNICK L BATTS DH REICHMAN RC

Citation: Lm. Demeter et al., PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 135-144

Authors: KESSLER HA HURWITZ S FARTHING C BENSON CA FEINBERG J KURITZKES DR BAILEY TC SAFRIN S STEIGBIGEL RT CHEESEMAN SH MCKINLEY GF WETTLAUFER B OWENS S NEVIN T KORVICK JA VALENTINE F DEHOLCZER L WEAVER D POTTAGE J URBANSKI P BARTLETT JG BECKER R REXROAD V SCHOOLEY R RAY G POWDERLY W GOULD M ROYAL M CALO J COLEMAN R MARIUZ P WEISSMAN E BURK RA AVATO J MANGINI L GRIECO M

Citation: Ha. Kessler et al., PILOT-STUDY OF TOPICAL TRIFLURIDINE FOR THE TREATMENT OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS HERPES-SIMPLEX-DISEASE IN PATIENTS WITH AIDS (ACTG-172), Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 147-152

Authors: REICHMAN RC MORSE GD DEMETER LM RESNICK L BASSIAKOS Y FISCHL M PARA M POWDERLY W LEEDOM J GREISBERGER C NEVIN T WOOD K MEEHAN PM GEHEB H COX S BATTS D TIMPONE J SLACK A ROYAL M QUESADA NR GEISELER PJ STARK N NEIDIG J HILL M

Citation: Rc. Reichman et al., PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 171(2), 1995, pp. 297-304